Parallax Volatility Advisers
ENZ

Parallax Volatility Advisers’s Enzo Biochem, Inc. ENZ Stock Holding History

Parallax Volatility Advisers’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17,000
Closed -$31.3K – 2686
2023
Q2 		$31.3K Hold
17,000
– – ﹤0.01% 2111
2023
Q1 		$41.3K Buy
+17,000
New +$25.3K ﹤0.01% 2241

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Parallax Volatility Advisers's ENZ Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of Enzo Biochem, Inc. (ENZ) in Q1 2018, closing a stake of 6,216 shares — an estimated $51K sold.

Parallax Volatility Advisers first reported a position in ENZ in Q4 2017 and held it in 1 quarter. The position peaked at $51K in Q4 2017. 107 funds tracked by Wall St. Rank hold ENZ as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining Enzo Biochem, Inc. position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 6,216 Enzo Biochem, Inc. shares in Q1 2018, an estimated $51K.
  • Parallax Volatility Advisers first reported a position in Enzo Biochem, Inc. in Q4 2017 and held it in 1 quarter.
  • Parallax Volatility Advisers's Enzo Biochem, Inc. position peaked at $51K in Q4 2017.
  • 107 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.